查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1572040

抗菌素抗藥性診斷市場：按產品類型、測試地點、設施類型分類 - 2025-2030 年全球預測

Antimicrobial Resistance Diagnostic Market by Product Type (Assays & Reagents, Diagnostic Tools), Testing Location (Laboratory Testing, Point-Of-Care Testing), Facility Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年抗生素抗藥性診斷市值為45.3億美元，預計到2024年將達到47.5億美元，複合年成長率為6.14%，預計到2030年將達到68.8億美元。

抗菌素抗藥性 (AMR) 診斷市場包括旨在識別病原體抗藥性模式和幫助治療決策的技術和產品。這包括分子測試、免疫測量、快速診斷試劑套件等。抗藥性感染疾病，這是一個重大的公共衛生挑戰。 AMR 診斷對於指南適當的抗生素使用的臨床實踐和幫助追蹤世界各地抗藥性模式的公共衛生監測都很重要。該市場服務於各種最終用戶，包括醫院、診所、實驗室、學術機構和研究機構。重要的成長要素包括對抗菌素抗藥性問題的認知提高、政府措施、診斷技術的進步以及減少抗生素濫用和過度使用的需要。照護現場診斷的快速發展以及人工智慧與診斷過程的整合正在為相關人員創造有希望的機會。然而，挑戰依然存在，包括先進診斷設備的高成本、監管障礙以及基礎設施投資的需求，特別是在低收入地區。關鍵的成長機會存在於開發適合資源有限環境的具有成本效益、易於使用的照護端設備。此外，開發能夠快速提供全面抗藥性光譜的下一代定序技術也具有潛力。公司應優先考慮滿足全球醫療保健需求的快速、經濟高效的診斷創新。加強公私夥伴關係可以加強研發工作並擴大市場範圍。該市場潛力巨大，但經濟限制、物流障礙以及部分地區滲透緩慢可能會阻礙成長。因此，重點關注創建意識提升計劃來教育醫療保健提供者了解 AMR 診斷的好處並提高使用率可能具有戰略意義。總體而言，建立夥伴關係、投資最尖端科技以及應對獨特的區域挑戰對於市場發展至關重要。

主要市場統計
基準年[2023] 45.3億美元
預測年份 [2024] 47.5億美元
預測年份 [2030] 68.8億美元
複合年成長率（%） 6.14%

市場動態：快速發展的抗菌素抗藥性診斷市場的關鍵市場洞察

供需的動態交互作用正在改變抗菌藥物抗藥性診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 抗菌素抗藥性日益普遍，導致對診斷解決方案的需求增加
    • 政府透過改進診斷措施對抗抗菌素抗藥性的努力和資金
    • 提高醫療保健專業人員和公眾對早期、準確的抗菌藥物抗藥性診斷重要性的認知
  • 市場限制因素
    • 與進階診斷測試相關的高成本
  • 市場機會
    • 跨夥伴關係合作，利用綜合診斷方法對抗抗菌素抗藥性
    • 投資專注於抗菌藥物抗藥性診斷創新的新興企業的機會
  • 市場挑戰
    • 各地區標準化通訊協定和法規缺乏統一

波特的五力：引領抗菌素抗藥性診斷市場的策略工具

波特的五力框架是了解抗菌素抗藥性診斷市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解抗菌素抗藥性診斷市場的外部影響

外部宏觀環境因素在塑造抗菌素抗藥性診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解抗菌藥物抗藥性診斷市場的競爭狀況

抗菌素抗藥性診斷市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣抗菌藥物抗藥性診斷市場供應商的績效評估

FPNV定位矩陣是評估抗菌藥物抗藥性診斷市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了抗菌素抗藥性診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，抗菌素抗藥性診斷市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 抗菌素抗藥性的流行增加了對診斷解決方案的需求
      • 政府透過改進診斷措施對抗抗菌素抗藥性的努力和資金
      • 醫療保健專業人員和公眾越來越意識到早期準確診斷抗菌藥物抗藥性的重要性。
    • 抑制因素
      • 與進階診斷測試相關的高成本
    • 機會
      • 跨部門夥伴關係，利用綜合診斷方法對抗抗菌素抗藥性
      • 投資專注於抗菌藥物抗藥性診斷創新的Start-Ups的機會
    • 任務
      • 不同地區的標準化通訊協定和法規缺乏統一
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章抗生素抗藥性診斷市場：依產品類型

  • 測定和試劑
    • 生物感測器
    • 單株抗體
  • 診斷工具
    • 裝置
    • 軟體和服務

第7章按測試地點分類的抗菌素抗藥性診斷市場

  • 臨床檢查
    • 恒溫核酸增幅技術（INAAT）
    • 聚合酵素鏈鎖反應(PCR)
  • 就地檢驗
    • 免疫檢測
    • 微陣列

第8章按設施類型分類的抗生素抗藥性診斷市場

  • 最終用戶
    • 診斷實驗室
    • 醫院和診所
  • 調查
    • CRO
    • 調查機構

第9章美洲抗菌素抗藥性診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區抗菌藥物抗藥性診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲抗菌藥物抗藥性診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-2B5802CFEB38

The Antimicrobial Resistance Diagnostic Market was valued at USD 4.53 billion in 2023, expected to reach USD 4.75 billion in 2024, and is projected to grow at a CAGR of 6.14%, to USD 6.88 billion by 2030.

The antimicrobials resistance (AMR) diagnostics market encompasses technologies and products aimed at identifying resistance patterns in pathogens to inform treatment decisions. This includes molecular tests, immunoassays, and rapid diagnostic kits. The necessity for these diagnostics is underscored by the rising prevalence of drug-resistant infections, which pose substantial public health challenges. AMR diagnostics are critical in both clinical settings-where they guide appropriate antibiotic usage-and in public health surveillance, helping track resistance patterns worldwide. The market serves various end-users, including hospitals, clinics, laboratories, academic institutions, and research organizations. Significant growth factors include increasing awareness of AMR issues, governmental initiatives, advancements in diagnostic technologies, and the necessity to reduce misuse and overuse of antibiotics. The rapid development of point-of-care diagnostics and integration of AI in diagnostic processes present promising opportunities for stakeholders. However, challenges persist, including high costs of advanced diagnostic equipment, regulatory hurdles, and the need for investment in infrastructure, particularly in low-income regions. Key growth opportunities exist in developing cost-effective, easy-to-use point-of-care devices suitable for resource-limited settings. Moreover, there is potential in the development of next-generation sequencing technologies that can provide comprehensive resistance profiles swiftly. Businesses should prioritize innovation in rapid, cost-effective diagnostics, which align with global healthcare needs. Increasing collaboration between public and private sectors can enhance research and development efforts, thus expanding market reach. While the market offers robust potential, its growth can be stymied by logistical barriers and the slow adoption rate in some regions due to economic constraints. Therefore, focusing on educating healthcare providers about the benefits of AMR diagnostics and creating awareness programs to enhance adoption could be strategic. Overall, forging partnerships, investing in cutting-edge technology, and addressing region-specific challenges are pivotal for market advancement.

KEY MARKET STATISTICS
Base Year [2023] USD 4.53 billion
Estimated Year [2024] USD 4.75 billion
Forecast Year [2030] USD 6.88 billion
CAGR (%) 6.14%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antimicrobial Resistance Diagnostic Market

The Antimicrobial Resistance Diagnostic Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of antimicrobial resistance leading to a higher demand for diagnostic solutions
    • Government initiatives and funding to combat antimicrobial resistance through improved diagnostics
    • Growing awareness among healthcare professionals and public about the importance of early and accurate antimicrobial resistance diagnosis
  • Market Restraints
    • High cost associated with advanced diagnostic tests
  • Market Opportunities
    • Cross-sector partnerships to combat antimicrobial resistance using comprehensive diagnostic approaches
    • Investment opportunities in startups focused on antimicrobial resistance diagnostic innovations
  • Market Challenges
    • Lack of standardization protocol and regulatory harmonization across various region

Porter's Five Forces: A Strategic Tool for Navigating the Antimicrobial Resistance Diagnostic Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antimicrobial Resistance Diagnostic Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antimicrobial Resistance Diagnostic Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antimicrobial Resistance Diagnostic Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antimicrobial Resistance Diagnostic Market

A detailed market share analysis in the Antimicrobial Resistance Diagnostic Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antimicrobial Resistance Diagnostic Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antimicrobial Resistance Diagnostic Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antimicrobial Resistance Diagnostic Market

A strategic analysis of the Antimicrobial Resistance Diagnostic Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Resistance Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Beckman Coulter, Becton, Dickinson and Company, BioFire Diagnostics, bioMerieux, Bruker Corporation, Cardinal Health, Cepheid, GenMark Diagnostics, GSK plc, Hoffmann-La Roche, Hologic, Inc., Luminex Corporation, Merck & Co., Inc., OpGen, Qiagen, Siemens Healthineers, T2 Biosystems, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Resistance Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Assays & Reagents and Diagnostic Tools. The Assays & Reagents is further studied across Biosensors and Monoclonal Anitbodies. The Diagnostic Tools is further studied across Instruments and Software & Services.
  • Based on Testing Location, market is studied across Laboratory Testing and Point-Of-Care Testing. The Laboratory Testing is further studied across Isothermal Nucleic Acid Amplification Technology (INAAT) and Polymerase Chain Reaction (PCR). The Point-Of-Care Testing is further studied across Immunoassays and Microarray.
  • Based on Facility Type, market is studied across End User and Research. The End User is further studied across Diagnostic Laboratories and Hospitals And Clinics. The Research is further studied across CROs and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of antimicrobial resistance leading to a higher demand for diagnostic solutions
      • 5.1.1.2. Government initiatives and funding to combat antimicrobial resistance through improved diagnostics
      • 5.1.1.3. Growing awareness among healthcare professionals and public about the importance of early and accurate antimicrobial resistance diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced diagnostic tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Cross-sector partnerships to combat antimicrobial resistance using comprehensive diagnostic approaches
      • 5.1.3.2. Investment opportunities in startups focused on antimicrobial resistance diagnostic innovations
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization protocol and regulatory harmonization across various region
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antimicrobial Resistance Diagnostic Market, by Product Type

  • 6.1. Introduction
  • 6.2. Assays & Reagents
    • 6.2.1. Biosensors
    • 6.2.2. Monoclonal Anitbodies
  • 6.3. Diagnostic Tools
    • 6.3.1. Instruments
    • 6.3.2. Software & Services

7. Antimicrobial Resistance Diagnostic Market, by Testing Location

  • 7.1. Introduction
  • 7.2. Laboratory Testing
    • 7.2.1. Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.2.2. Polymerase Chain Reaction (PCR)
  • 7.3. Point-Of-Care Testing
    • 7.3.1. Immunoassays
    • 7.3.2. Microarray

8. Antimicrobial Resistance Diagnostic Market, by Facility Type

  • 8.1. Introduction
  • 8.2. End User
    • 8.2.1. Diagnostic Laboratories
    • 8.2.2. Hospitals And Clinics
  • 8.3. Research
    • 8.3.1. CROs
    • 8.3.2. Research Institutes

9. Americas Antimicrobial Resistance Diagnostic Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Antimicrobial Resistance Diagnostic Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Antimicrobial Resistance Diagnostic Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

LIST OF FIGURES

  • FIGURE 1. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MONOCLONAL ANITBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 193. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 196. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 201. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 202. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 204. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 205. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 218. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 220. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 221. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 222. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 223. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 224. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 227. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 229. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 230. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 231. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 232. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 233. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 236. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 238. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 239. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 240. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 241. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 242. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 245. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 247. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 248. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 249. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 250. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 251. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 254. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 256. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 257. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 258. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 259. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 260. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 263. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 265. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 266. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 267. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 268. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 269. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 272. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 274. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 275. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 276. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 277. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 278. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 281. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 283. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 284. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 285. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 286. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 287. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 290. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 292. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MAR